Albert Zlotnik
44Patents
9h-index
69Co-inventors
78Inventor score
Filing activity: Oct 25, 1994 → Aug 21, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7025962B1 | Mammalian cell surface antigens; related reagents | Emerging Cross-Sectional Technologies | 101 | Expired |
| US6111090A | Mammalian cell surface antigens; related reagents | Emerging Cross-Sectional Technologies | 99 | Expired |
| US8633186B2 | Modulation of chemosensory receptors and ligands associated therewith | Physics | 60 | Active |
| US7928111B2 | Compounds including substituted thienopyrimidinone derivatives as ligands for modulating chemosensory receptors | Physics | 48 | Active |
| US8541421B2 | Methods of enhancing sweet taste of compositions using substituted thieno{2,3-D}pyrimidines | Physics | 27 | Active |
| US9181276B2 | Modulation of chemosensory receptors and ligands associated therewith | Physics | 22 | Active |
| US5837232A | Use of an interleukin-10 antagonist to treat a B cell mediated autoimmune disorder | Emerging Cross-Sectional Technologies | 18 | Expired |
| US9603848B2 | Modulation of chemosensory receptors and ligands associated therewith | Physics | 18 | Active |
| US7115379B1 | Anti-mammalian CX3C cytokine antibodies | Emerging Cross-Sectional Technologies | 13 | Expired |
| US6548654B1 | DNA encoding mammalian CX3C chemokine genes | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6566503B2 | Mammalian CX3C chemokine | Chemistry; Metallurgy | 7 | Expired |
| US6949243B1 | Methods of inhibiting metastasis | Human Necessities | 7 | Expired |
| US6645491B1 | Method for treating inflammatory conditions using an antibody to MIP-3&agr; | Human Necessities | 6 | Expired |
| US7431924B2 | Methods of treating inflammation using mammalian CX3C chemokine antibodies | Emerging Cross-Sectional Technologies | 5 | Active |
| US5837293A | Use of interleukin-10 analogs for antagonists to treat endotoxin- or superantigen-induced toxicity | Emerging Cross-Sectional Technologies | 5 | Expired |
| US7279460B2 | Chemokine TECK polypeptides | Chemistry; Metallurgy | 4 | Expired |
| US7932058B2 | Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assays | Physics | 4 | Active |
| US5858707A | Purified mammalian nucleobase permeases; nucleic acids; antibodies | Chemistry; Metallurgy | 4 | Expired |
| US7585502B2 | Mammalian CX3C chemokine antibodies | Emerging Cross-Sectional Technologies | 3 | Active |
| US5985580A | Antibodies which specifically bind to the thymokine lymphotactin | Emerging Cross-Sectional Technologies | 3 | Expired |
| US6723520B2 | Antibodies that bind chemokine teck | Chemistry; Metallurgy | 3 | Expired |
| US7101987B2 | CCL27 polypeptides | Chemistry; Metallurgy | 3 | Expired |
| US8669066B2 | Rationale, methods, and assays for identifying human and non-human primate taste specific genes and use thereof in taste modulator and therapeutic screening assays | Physics | 3 | Active |
| US5833976A | Use of interleukin-10 (IL-10) to treat endotoxin- or superantigen-induced toxicity | Emerging Cross-Sectional Technologies | 2 | Expired |
| US7785804B2 | Mammalian CX3C chemokine antibodies | Emerging Cross-Sectional Technologies | 2 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.